seed
Stage
2
Investors
About
Invitris develops cell-free protein synthesis technology enabling rapid, scalable production of complex proteins for applications in biopharmaceuticals, industrial biotechnology, and agriculture.
Explore Invitris's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.